Estrogen-Receptor Negative Breast Cancer is related to hereditary breast cancer and body mass index quantitative trait locus 11. An important gene associated with Estrogen-Receptor Negative Breast Cancer is MIR373 (MicroRNA 373), and among its related pathways/superpathways are Infectious disease and ERK Signaling. The drugs Gemcitabine and Progesterone have been mentioned in the context of this disorder. Affiliated tissues include breast and brain, and related phenotypes are Decreased viability and Decreased viability in pancreas lineage